Venlafaxine (venlafaxine hydrochloride) NDC 65862-404

NDC codes

FDA NDC Directory

Product NDC (as listed)65862-404Labeler and product segments. Claims need a package NDC.

Product NDC at billing width65862-0404Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
65862-404-01	65862040401	100 TABLET in 1 BOTTLE (65862-404-01)Marketed from Apr 7, 2010
65862-404-10	65862040410	10 BLISTER PACK in 1 CARTON (65862-404-10) / 10 TABLET in 1 BLISTER PACKMarketed from Apr 7, 2010
65862-404-30	65862040430	30 TABLET in 1 BOTTLE (65862-404-30)Marketed from Apr 7, 2010
65862-404-60	65862040460	60 TABLET in 1 BOTTLE (65862-404-60)Marketed from Apr 7, 2010
65862-404-71	65862040471	7000 TABLET in 1 BOTTLE (65862-404-71)Marketed from Apr 7, 2010
65862-404-90	65862040490	90 TABLET in 1 BOTTLE (65862-404-90)Marketed from Apr 7, 2010
65862-404-99	65862040499	1000 TABLET in 1 BOTTLE (65862-404-99)Marketed from Apr 7, 2010

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Venlafaxine
Generic name (nonproprietary): venlafaxine hydrochloride
Active ingredients: Venlafaxine hydrochloride — 25 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Aurobindo Pharma Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 090555
Marketing start: Apr 7, 2010
Listing expires: Dec 31, 2026
Other FDA classes: Norepinephrine Uptake Inhibitors (Mechanism)Serotonin Uptake Inhibitors (Mechanism)
Identifiers: Product ID 65862-404_426d12db-50e2-4915-999f-84645fb387d9SPL ID 426d12db-50e2-4915-999f-84645fb387d9SPL set ID b23637e5-d37f-41b5-ba76-fc053e903bc2RxCUI 313580, 313582, 313584, 313586, 314277UNII 7D7RX5A8MO
Pharmacologic class: Serotonin and Norepinephrine Reuptake Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862040401 followed by a unit qualifier and the quantity

Package 65862-0404-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 21, 2023. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Venlafaxine tablets, USP are indicated for the treatment of major depressive disorder. The efficacy of venlafaxine tablets, USP in the treatment of major depressive disorder was established in 6-week controlled trials of adult outpatients whose diagnoses corresponded most closely to the DSM-III or DSM-III-R category of major depression and in a 4-week controlled trial of inpatients meeting diagnostic criteria for major depression with melancholia (see CLINICAL TRIALS ). A major depressive episode implies a prominent and relatively persistent depressed or dysphoric mood that usually interferes with daily functioning (nearly every day for at least 2 weeks); it should incl…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)